Literature DB >> 1654196

Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study.

S Shiina1, K Tagawa, T Unuma, R Takanashi, K Yoshiura, Y Komatsu, Y Hata, Y Niwa, Y Shiratori, A Terano.   

Abstract

Histopathologic examination was done on 18 cases after percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma. In eight cases, the lesion was treated by PEIT alone; in the other ten cases, PEIT was combined with transcatheter arterial embolization. The lesion was completely necrotic in 13 cases, 90% necrotic in four cases, and 70% necrotic in the rest. In addition, PEIT seemed to be effective against intercapsular, extracapsular, and vascular invasions. In the four cases of incomplete necrosis, the viable cancer tissue remained in small tumor nodules around the main tumor, in portions isolated by septa, or along the edge of the lesion. Therefore, ethanol should be injected not only into the center of the lesion, but also into sites close to its edge. Ethanol did not damage noncancerous liver parenchyma distant from injected sites. Local dissemination of the cancer cells was not found in any case. Therefore, PEIT seems to be a valuable therapy and may be an alternative to surgery in some cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654196     DOI: 10.1002/1097-0142(19911001)68:7<1524::aid-cncr2820680711>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

2.  Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model.

Authors:  Yang Gao; Yonghua Gao; Weijie Guan; Liyan Huang; Xiaoming Xu; Chenting Zhang; Xiuqing Chen; Yizhuang Wu; Guangqiao Zeng; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 3.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Successful removal of a giant skull base metastasis from hepatocellular carcinoma after direct ethanol injection: case report.

Authors:  T Isaka; H Nakagawa; T Suzuki; J Yamada; K Wada; T Kadota
Journal:  Skull Base Surg       Date:  2000

Review 5.  Image-guided percutaneous ablation therapies for hepatocellular carcinoma.

Authors:  Shuichiro Shiina
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 6.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

7.  Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.

Authors:  Joo Han Oh; Pil Whan Yoon; Sang Hoon Lee; Hwan Seong Cho; Woo Sung Kim; Han-Soo Kim
Journal:  Int Orthop       Date:  2006-05-31       Impact factor: 3.075

Review 8.  Screening for hepatocellular carcinoma: why, when, how?

Authors:  Miguel R Arguedas
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system.

Authors:  Takashi Maeda; Jaesung Hong; Kozo Konishi; Takanori Nakatsuji; Takefumi Yasunaga; Yo-ichi Yamashita; Akinobu Taketomi; Kazuhiro Kotoh; Munechika Enjoji; Hideaki Nakashima; Kazuo Tanoue; Yoshihiko Maehara; Makoto Hashizume
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea.

Authors:  Yon Mi Sung; Dongil Choi; Hyo K Lim; Won Jae Lee; Seung Hoon Kim; Min Ju Kim; Seung Woon Paik; Byung Chul Yoo; Kwang Cheol Koh; Joon Hyoek Lee; Moon Seok Choi
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.